RESMED INC — Director's Dealing 2011

Aug 12, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-08-10

Reporting Person: FARRELL PETER C (Director, CEO and Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-10	ResMed Common Stock	M	10388	$19.250	Acquired	701008	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-10	ResMed Common Stock Options	$19.250	M	10388	Disposed	2016-02-03	ResMed Common Stock (10388)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	3317	Indirect
ResMed Common Stock	21391	Indirect
Resmed Common Stock	200000	Indirect

Footnotes

F1: Represents date options first became exercisable.